183 related articles for article (PubMed ID: 27851713)
21. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.
Jourdain G; Le Cœur S; Ngo-Giang-Huong N; Traisathit P; Cressey TR; Fregonese F; Leurent B; Collins IJ; Techapornroong M; Banchongkit S; Buranabanjasatean S; Halue G; Nilmanat A; Luekamlung N; Klinbuayaem V; Chutanunta A; Kantipong P; Bowonwatanuwong C; Lertkoonalak R; Leenasirimakul P; Tansuphasawasdikul S; Sang-A-Gad P; Pathipvanich P; Thongbuaban S; Wittayapraparat P; Eiamsirikit N; Buranawanitchakorn Y; Yutthakasemsunt N; Winiyakul N; Decker L; Barbier S; Koetsawang S; Sirirungsi W; McIntosh K; Thanprasertsuk S; Lallemant M;
PLoS Med; 2013 Aug; 10(8):e1001494. PubMed ID: 23940461
[TBL] [Abstract][Full Text] [Related]
22. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN
Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038
[TBL] [Abstract][Full Text] [Related]
23. Association between prescription cost sharing and adherence to initial combination antiretroviral therapy in commercially insured antiretroviral-naïve patients with HIV.
Johnston SS; Juday T; Seekins D; Espindle D; Chu BC
J Manag Care Pharm; 2012 Mar; 18(2):129-45. PubMed ID: 22380472
[TBL] [Abstract][Full Text] [Related]
24. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations.
Cunningham WE; Nance RM; Golin CE; Flynn P; Knight K; Beckwith CG; Kuo I; Spaulding A; Taxman FS; Altice F; Delaney JA; Crane HM; Springer SA
BMC Infect Dis; 2019 Oct; 19(1):913. PubMed ID: 31664910
[TBL] [Abstract][Full Text] [Related]
25. Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy.
Ochieng W; Kitawi RC; Nzomo TJ; Mwatelah RS; Kimulwo MJ; Ochieng DJ; Kinyua J; Lagat N; Onyango KO; Lwembe RM; Mwamburi M; Ogutu BR; Oloo FA; Aman R
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):e49-56. PubMed ID: 26009836
[TBL] [Abstract][Full Text] [Related]
26. Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.
Gras L; de Wolf F; Smit C; Prins M; van der Meer JT; Vanhommerig JW; Zwinderman AH; Schinkel J; Geskus RB;
J Acquir Immune Defic Syndr; 2015 Apr; 68(5):536-42. PubMed ID: 25559595
[TBL] [Abstract][Full Text] [Related]
27. The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy: a systematic review.
Soeters HM; Napravnik S; Patel MR; Eron JJ; Van Rie A
AIDS; 2014 Jan; 28(2):245-55. PubMed ID: 24072197
[TBL] [Abstract][Full Text] [Related]
28. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
[TBL] [Abstract][Full Text] [Related]
29. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
Butler K; Inshaw J; Ford D; Bernays S; Scott K; Kenny J; Klein N; Turkova A; Harper L; Nastouli E; Paparini S; Choudhury R; Rhodes T; Babiker A; Gibb D
Health Technol Assess; 2016 Jun; 20(49):1-108. PubMed ID: 27377073
[TBL] [Abstract][Full Text] [Related]
30. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
; Young J; Psichogiou M; Meyer L; Ayayi S; Grabar S; Raffi F; Reiss P; Gazzard B; Sharland M; Gutierrez F; Obel N; Kirk O; Miro JM; Furrer H; Castagna A; De Wit S; Muñoz J; Kjaer J; Grarup J; Chêne G; Bucher H
PLoS Med; 2012; 9(3):e1001194. PubMed ID: 22448150
[TBL] [Abstract][Full Text] [Related]
31. The Treatment Cascade in Children With Unsuppressed Viral Load-A Reality Check in Rural Lesotho, Southern Africa.
Lejone TI; Ringera I; Cheleboi M; Wagner S; Muhairwe J; Klimkait T; Labhardt ND
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):250-256. PubMed ID: 29189416
[TBL] [Abstract][Full Text] [Related]
32. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
33. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with 10 years of continuous viral load suppression on HAART.
Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
[TBL] [Abstract][Full Text] [Related]
35. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
Wolbers M; Babiker A; Sabin C; Young J; Dorrucci M; Chêne G; Mussini C; Porter K; Bucher HC;
PLoS Med; 2010 Feb; 7(2):e1000239. PubMed ID: 20186270
[TBL] [Abstract][Full Text] [Related]
37. Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
Belaunzarán-Zamudio PF; Naranjo L; Caro-Vega Y; Castillo-Mancilla JR; Camiro-Zuñiga A; Fuentes-García R; Crabtree-Ramírez BE; Sierra-Madero JG
AIDS Res Hum Retroviruses; 2023 Mar; 39(3):136-144. PubMed ID: 36597354
[TBL] [Abstract][Full Text] [Related]
38. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
[TBL] [Abstract][Full Text] [Related]
39. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population.
Zaragoza-Macias E; Cosco D; Nguyen ML; Del Rio C; Lennox J
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):133-8. PubMed ID: 20156096
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
